Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2025-04-03 00:00:00 ET · period of report 2025-04-01 · accession 0001601830-25-000055 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-03 | 2025-04-01 | RXRX | Dar Zavain | Dir | A - Grant | $0.00 | +2,745 | 110.9K | +3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-04-01 | A | A | 2,745 | $0.00 | 110,877 | D | — | — |